Status:
COMPLETED
Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers
Lead Sponsor:
Xenon Pharmaceuticals Inc.
Conditions:
Healthy Human Volunteers
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple doses of XPF-001 in healthy volunteers. The effect of food on the pharmacokinetics of XPF-0...
Eligibility Criteria
Inclusion
- Healthy subjects (Females of non-childbearing potential) with normal or clinically insignificant laboratory results, ECGs and physical examinations.
Exclusion
- Subjects with a presence or history of any clinically significant disease.
- Subjects who have participated in and investigational drug trial within 60 days of admission.
- Subjects who have used tobacco or nictoine products in the 1 month prior to admission
- Females who are pregnant or breastfeeding
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00813670
Start Date
November 1 2008
End Date
July 1 2009
Last Update
September 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anapharm
Montreal, Quebec, Canada